Skip to main content

Table 2 Odds ratios (OR) for remission of obesity-associated comorbidities and its components between surgery groups (SG vs.GB) at 6-, 12- and 24-months follow-up

From: Two-year outcomes of sleeve gastrectomy versus gastric bypass: first report based on Tehran obesity treatment study (TOTS)

Obesity-comorbidities

Follow up (months)

Propensity score-adjusted OR

95% CI

P value

T2DM remission

6

0.82

0.51–1.31

0.412

12

1.15

0.69–1.91

0.574

24

2.00

0.88–4.54

0.096

HTN remission

6

0.79

0.56–1.10

0.169

12

0.96

0.68–1.36

0.850

24

2.10

1.22–3.60

0.007

Dyslipidemia remission

6

1.30

1.00–1.69

0.044

12

1.86

1.47–2.35

0.000

24

2.59

1.58–4.24

0.000

  1. T2DM Type 2 diabetes mellitus, HTN hypertension